Test for hormone-disrupting chemicals gets global seal of approval

January 29, 2013 in Other

A test for hormone-disrupting pollutants, originally developed at the University of California, Davis, has been approved as an international standard by the Organization of Economic Cooperation and Development as well as by the U.S. government.

"Endocrine disruptors" are chemicals that interfere with the action of hormones on cells. There has been growing concern that such chemicals, from a wide variety of products, might have an impact on both and the environment.

Hormones such as estrogen act on cells by triggering a receptor on the , setting off a chain of events inside the cell. The new test uses a cell line, BG1Luc4e2, which produces a glowing firefly protein called luciferase when exposed to estrogens or similar chemicals.

The test was originally created by Professor Michael Denison and colleagues at the UC Davis Department of Environmental Toxicology. It has been validated by the National Toxicology Program at the U.S. Department of Health and Human Services and by the U.S. , and now by the OECD.

The test is licensed to users through UC Davis, in collaboration with UC San Diego and Promega, Inc. of Madison, Wisc., and which own patents on some components of the test. Typical customers are companies that carry out environmental testing for clients.

More information: OECD Performance standards for test (pdf) www.oecd.org/env/e… r%202012.pdf

Provided by UC Davis search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Early use of tracheostomy for mechanically ventilated patients not associated with improved survival

For critically ill patients receiving mechanical ventilation, early tracheostomy (within the first 4 days after admission) was not associated with an improvement in the risk of death within 30 days compared to patients who ...

Other created 12 hours ago | popularity not rated yet | comments 0

Decisions to forgo life support may depend heavily on the ICU where patients are treated

The decision to limit life support in patients in the intensive care unit (ICU) appears to be significantly influenced by physician practices and/or the culture of the hospital, suggests new findings from researchers at the ...

Other created 14 hours ago | popularity not rated yet | comments 0

People on higher incomes are happier with new knees

Knee replacement surgery is a very common procedure. However, it does not always resolve function or pain in all the recipients of new knees. A study by Robert Barrack, MD and his colleagues from the Washington University ...

Other created 16 hours ago | popularity not rated yet | comments 0

New search engine finds rare diagnoses

Doctors are trained to think "common disease" when they meet patients in their practices, and as they rarely or never meet a rare disease, it often takes many years to reach the right diagnosis. A new search tool called FindZebra ...

Other created 17 hours ago | popularity not rated yet | comments 0

Delayed transfer to the ICU increases risk of death in hospital patients

Delayed transfer to the intensive care unit (ICU) in hospitalized patients significantly increases the risk of dying in the hospital, according to a new study from researchers in Chicago.

Other created 18 hours ago | popularity not rated yet | comments 0


Phthalates: Study links chemicals widely found in plastics, processed food to elevated blood pressure in children, teens

Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the ...

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...